首 页
医药产品
医保药品
中标目录
医药招标
数据中心
医学资料
医药新闻
医药展会
OTC药品
保健品
医疗器械
处方药
专科药
中医药
器械中标目录
药品批发行情
求购信息
医药下载
药价简讯
当前位置:药药网 / 药品 / 美国NDC复合药物数据库文件(本栏目收费,不能显示细节,电话13136136841)
药品名称:
商品名称:
药品NDC:
报告期内:
-
格式:2020-5-3
NDC包装id:
市场分类:
不限
ANDA
BLA
NDA
EMERGENCY USE AUTHORIZATION
NDA AUTHORIZED GENERIC
OTC MONOGRAPH FINAL
OTC MONOGRAPH NOT FINAL
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
UNAPPROVED DRUG OTHER
UNAPPROVED HOMEOPATHIC
UNAPPROVED MEDICAL GAS
活性成分:
持证企业:
美国药品NDC(国家药品编码)与药品说明书数据库
美国NDC未完成药物数据库文件
美国NDC复合药物数据库文件
美国NDC 数据库排除药物数据库文件
 美国NDC复合药物数据库文件1279条(本栏目收费,不能显示细节,电话13136136841)
药品名称(分析)
商品名
药品NDC
专利人(分析)
报告期内
活性成分
市场分类
规格(分析)
NDC包装id
Ephedrine 5 mg/mL in 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
70004-604
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
EPHEDRINE SULFATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5 mg/1 mL
70004-604-09
Phenylephrine 16 mg/mL in 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
70004-825
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.16 mg/1 mL
70004-825-40
Hydromorphone HCL 0.1mg/ml in D5W
HUMAN COMPOUNDED DRUG
71286-2013
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
HYDROMORPHONE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.1 mg/1 mL
71286-2013-2
Hydromorphone HCL 0.5mg/ml in NS
HUMAN COMPOUNDED DRUG
71286-2011
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
HYDROMORPHONE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.5 mg/1 mL
71286-2011-1
Hydromorphone HCL 1mg/ml in NS
HUMAN COMPOUNDED DRUG
71286-2012
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
HYDROMORPHONE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
71286-2012-1
Ketamine 50mg/ml
HUMAN COMPOUNDED DRUG
71286-3020
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
KETAMINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 mg/1 mL
71286-3020-1
Fentanyl 2mcg/ml Bupivacaine 0.0625% in NS
HUMAN COMPOUNDED DRUG
71286-2081
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
FENTANYL CITRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 ug/1 mL
71286-2081-1
Labetalol Hydrochloride
HUMAN COMPOUNDED DRUG
65302-503
The Ritedose Corporation
2021/2/1 0:00:00
LABETALOL HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5 mg/1 mL
65302-503-04
Succinylcholine Chloride
HUMAN COMPOUNDED DRUG
65302-504
The Ritedose Corporation
2021/2/1 0:00:00
SUCCINYLCHOLINE CHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/1 mL
65302-504-05
Succinylcholine Chloride
HUMAN COMPOUNDED DRUG
65302-504
The Ritedose Corporation
2021/2/1 0:00:00
SUCCINYLCHOLINE CHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/1 mL
65302-504-10
Phenylephrine Hydrochloride
HUMAN COMPOUNDED DRUG
65302-505
The Ritedose Corporation
2021/2/1 0:00:00
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
80 ug/1 mL
65302-505-10
Neostigmine Methylsulfate
HUMAN COMPOUNDED DRUG
65302-501
The Ritedose Corporation
2021/2/1 0:00:00
NEOSTIGMINE METHYLSULFATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
65302-501-03
Neostigmine Methylsulfate
HUMAN COMPOUNDED DRUG
65302-501
The Ritedose Corporation
2021/2/1 0:00:00
NEOSTIGMINE METHYLSULFATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
65302-501-05
Phenylephrine Hydrochloride
HUMAN COMPOUNDED DRUG
65302-506
The Ritedose Corporation
2021/2/1 0:00:00
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
100 ug/1 mL
65302-506-10
Estradiol Pellet
HUMAN COMPOUNDED DRUG
77437-024
Strukmyer
2021/2/1 0:00:00
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg
77437-024-25
Estradiol Pellet
HUMAN COMPOUNDED DRUG
77437-026
Strukmyer
2021/2/1 0:00:00
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
15 mg
77437-026-25
Fentanyl 2 mcg/mL and Ropivacaine 0.1% in 0.9% Sodium Chloride PF
HUMAN COMPOUNDED DRUG
70004-264
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
FENTANYL CITRATE; ROPIVACAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.002 mg/1 mL; 1 mg/1 mL
70004-264-22
Glycopyrrolate 0.2 mg/mL
HUMAN COMPOUNDED DRUG
70004-638
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
GLYCOPYRROLATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.2 mg/1 mL
70004-638-09
Fentanyl 5 mcg/mL and Bupivacaine 0.075% PF in 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
70004-251
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
FENTANYL CITRATE; BUPIVACAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.005 mg/1 mL; .75 mg/1 mL
70004-251-64
glutathione 200mg/ml
HUMAN COMPOUNDED DRUG
80098-017
STASKA PHARMACEUTICALS, INC.
2021/2/1 0:00:00
GLUTATHIONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
200 mg/1 mL
80098-017-01
首页
(current)
46
(current)
47
(current)
48
(current)
49
(current)
50
(current)
51
(current)
52
(current)
53
(current)
54
(current)
55
(current)
(current)
末页
(current)
网站地图
-
网站开发
-
网站简介
-
会员服务
-
法律声明
-
联系我们
-
药品招商频道
-
药品信息排行
-
2018年版国家基本药物目录
-
意见反馈
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:
国家药品监督管理局
|
国家中医药管理局
|
SDA药品评审中心
|
医加医疗器械
|
膏药生产厂家
|
爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究 客服热线:0575-83552251 / 13754370441 QQ客服:
浙ICP备16010490号-2
增值电信业务经营许可证:
浙B2-20220931
互联网药品信息服务资格证书编号:
(浙)-经营性2023-0215
浙公网安备:330683240604819103159
医药代理商群1:
医药代理商群2:
医药代理商群3: